Search Results - "Mansourbakht, T"

FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Entérologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II study by Taïeb, J, Lecomte, T, Aparicio, T, Asnacios, A, Mansourbakht, T, Artru, P, Fallik, D, Spano, JP, Landi, B, Lledo, G, Desrame, J

“…Background: The purpose of the study was to prospectively evaluate the efficacy and tolerability of the FOLFIRI.3 regimen in patients with unresectable…”
Get full text

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials by Barbier, Emilie, François, Eric, Michel, Pierre, Rougier, Philippe, Seitz, Jean-François, Aouakli, A., Bedjaoui, A., Botton, A., Cadier-Lagnes, A., Hollebecque, A., Lemaire, A., Marre, A., Villing, A.L., Denis, B., Becht, C., Bineau, C., Borel, C., Buffet, C., Cornila, C., Couffon, C., Locher, C., Rebischung, C., Sarda, C., Auby, D., Baudet-Klepping, D., Besson, D., Cleau, D., Festin, D., Genet, D., Peré-Vergé, D., Pillon, D., Smith, D., Dorval Danquechin, E., Maillard, E., Mitry, E., Suc, E., Zrihen, E., Pariente, E.A., Dewaele, F., Di Fiore, F., Husseini, F., Kikolski, F., Petit-Laurent, F., Zerouala-Boussaha, F., Caroli-Bosc, F.X., Boilleau-Jolimoy, G., Medinger, G., Graber, I., Charneau, J., Cretin, J., Deguiral, J., Lacourt, J., Meunier, J., Vincent, J., Volet, J., Barbare, J.C., Paitel, J.F., Raoul, J.L., Gornet, J.M., Aucouturier, J.P., Barbieux, J.P., Plachot, J.P., Ramain, J.P., Spano, J.P., Bouhier-Leporrier, K., Cany, L., Rob, L., Baconnier, M., Benchalal, M., Combe, M., Duluc, M., Giovannini, M., Mabro, M., Ramdani, M., Tissot, M., Clavero-Fabri, M.C., Gouttebel, M.C., Kaminsky, M.C., Stremsdoerfer, N., Burtin, P., Cassan, P., Claudé, P., Couzigou, P., Geoffroy, P., Godeau, P., Hammel, P., Novello, P., Prost, P., Ruszniewski, P., Texereau, P., Coriat, R., Nasca, S., Fratte, S.P., Mansourbakht, T., Walter, T., Derias, V., Jestin Le Tallec, V., Sebbagh, V., Adhoute, X., Becouarn, Y.

“…Previous studies showed that high and low body mass index (BMI) was associated with worse prognosis in early-stage colorectal cancer (CRC), and low BMI was…”
Get full text

1587P - Sarcopenia Affects Treatment Toxicity in Metastatic Colorectal Cancer Patients: Results of a Prospective Multicenter Study by Barret, M., Dalban, C., Taieb, J., Malka, D., Mansourbakht, T., Latko, E., Antoun, S.

“…Malnutrition reduces tolerance to treatment, quality of life, and survival in numerous cancers, including metastatic colorectal cancer (mCRC). Previous studies…”
Get full text

Sarcopenia Affects Treatment Toxicity in Metastatic Colorectal Cancer Patients: Results of a Prospective Multicenter Study by Barret, M., Dalban, C., Taieb, J., Malka, D., Mansourbakht, T., Latko, E., Antoun, S.

Get full text

Gemcitabine plus oxaliplatin (GemOx) in advanced hepatocellular carcinoma (HCC): A multicenter study of over 200 patients by Williet, N., Zaanan, A., Hebbar, M., Boige, V., Fartoux, L., Mansourbakht, T., Dubreuil, O., Rosmorduc, O., Bonnetain, F., Taïeb, J.

“…Abstract only…”
Get full text

Does nutritional status affect treatment tolerability and efficacy in metastatic colorectal cancer (mCRC) patients? Results of a prospective multicenter study by Barret, M., Malka, D., Aparicio, T., Bonnetain, F., Dalban, C., Locher, C., Sabate, J., Louafi, S., Mansourbakht, T., Attar, A., Taïeb, J.

“…Abstract only…”
Get full text

Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules by Taïeb, Julien, Bonyhay, Luminita, Golli, Lamia, Ducreux, Michel, Boleslawski, Emmanuel, Tigaud, Jean‐Marie, de Baere, Thierry, Mansourbakht, Touraj, Delgado, Marie Anna, Hannoun, Laureut, Poynard, Thierry, Boige, Valerie

“…BACKGROUND New therapies are needed to improve the prognosis of patients with advanced hepatocellular carcinoma (HCC). Various gemcitabine‐oxaliplatin…”
Get full text

Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma (AHCC): results of a phase II study by Taieb, J., Mansourbakht, T., Ducreux, M., Bonyhay, L., De Baere, T., Delgado, M., Poynard, T., Boige, V.

“…Abstract only…”
Get full text

Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma (AHCC): results of a phase II study by Taieb, J., Mansourbakht, T., Ducreux, M., Bonyhay, L., De Baere, T., Delgado, M., Poynard, T., Boige, V.

“…Abstract only…”
Get full text

5-FU/ folinic acid plus CPT-11 (FOLFIRI.3 regimen) in advanced pancreatic carcinoma (PC): results of an AGEO phase II study by Taieb, J., Lecomte, T., Artru, P., Aparicio, T., Mansourbakht, T., Landi, B., Béchade, D., Germann, N., Poynard, T., Lledo, G., Desrame, J.

“…Abstract only…”
Get full text

Oxaliplatin in gastro-intestinal tract cancer except colorectal cancer by Louafi, Samy, Mansourbakht, Touraj, Bonyhay, Luminita, Taïeb, Julien

“…In a few years, oxaliplatin became a standard treatment of colorectal cancer not only in metastatic situation but also in the adjuvant setting. In the others…”
Get more information

Post-fracture osteolysis of the pubic bone simulating a malignancy: Report of a case by Botton, Estelle, Saraux, Alain, Malhaire, Jean-Pierre, Mansourbakht, Touraj, Jousse, Sandrine, Le Goff, Paul, Labat, Jean-Paul

“…Post-fracture osteolysis of the pubic bone is rare. We report a case of a 70-year-old woman with osteoporosis and a history of radiation therapy 2 years…”
Get full text

CO.32 Chimiothérapie des adénocarcinomes avancés de l’intestin grêle : résultats finaux de l’étude multicentrique AGEO by Zaanan, A., Costes, L., Liegard, M., Locher, C., Bidault, A., Mitry, E., Gornet, J.M., Tourgeron, D., Mansourbakht, T., Taieb, J., Lecomte, T., Moulin, V., Maire, F., Sobhani, I., Afchain, P., Malka, D., Bonnetain, F., Aparicio, T.

“…Les adénocarcinomes de l’intestin grêle (AIG) sont des tumeurs rares et de mauvais pronostic. Les données concernant la chimiothérapie des AIG avancés sont peu…”
Get full text